ATC code H05
ATC code H05 Calcium homeostasis is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2] Subgroup H05 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[3]
| ATC codes |
|---|
| H Systemic hormonal preparations, excluding sex hormones and insulins |
| H01 Pituitary and hypothalamic hormones and analogues |
| H02 Corticosteroids for systemic use |
| H03 Thyroid therapy |
| H04 Pancreatic hormones |
| H05 Calcium homeostasis |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH05.[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
H05A Parathyroid hormones and analogues
H05AA Parathyroid hormones and analogues
- H05AA01 Parathyroid gland extract
- H05AA02 Teriparatide
- H05AA03 Parathyroid hormone
- H05AA04 Abaloparatide
H05B Anti-parathyroid agents
H05BA Calcitonin preparations
H05BX Other anti-parathyroid agents
- H05BX01 Cinacalcet
- H05BX02 Paricalcitol
- H05BX03 Doxercalciferol
- H05BX04 Etelcalcetide
- H05BX05 Calcifediol
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 2020-02-01.
- "ATC-Klassifikation mit definierten Tagesdosen DDD" (in German). German Institute for Medical Documentation and Information. Retrieved 2020-02-01.
- "ATC/DDD Index 2021: code H05". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2021: code QH05". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.